{"id":"W2749614740","doi":"10.1093/jjco/hyx114","title":"A Phase 1/1b tolerability study of rilotumumab alone or in combination with cisplatin and capecitabine in Japanese patients with gastric cancer","year":2017,"lang":"en","type":"article","venue":"Japanese Journal of Clinical Oncology","topic":"Liver physiology and pathology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Amgen Canada; Amgen","keywords":"Medicine; Capecitabine; Tolerability; Internal medicine; Adverse effect; Gastroenterology; Cancer; Cisplatin; Nausea; Pharmacokinetics; Phases of clinical research; Chemotherapy; Oncology; Colorectal cancer","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001400867,0.001222878,0.00217446,0.0003371114,0.0003755165,0.0004935269,0.0006067944,0.0006191006,0.001421249],"category_scores_gemma":[0.0006832262,0.000548075,0.0009995045,0.0003822873,0.0006654613,0.0005264673,0.0002419395,0.001576286,0.0003944886],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007909434,"about_ca_system_score_gemma":0.001276659,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001445626,"about_ca_topic_score_gemma":0.004052144,"domain_scores_codex":[0.9995685,0.0002155924,0.00002943261,0.00008409137,0.00004560829,0.00005676644],"domain_scores_gemma":[0.999549,0.00004987885,0.000125261,0.00003470992,0.00004355675,0.0001975236],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5653527,0.06570252,0.03834132,0.002621714,0.003714367,0.0008567338,0.001261172,0.003000915,0.1751629,0.000156075,0.003634203,0.1401953],"study_design_scores_gemma":[0.2893106,0.6245636,0.07385857,0.00004379764,0.001378621,0.0007518668,0.0001200602,0.001117124,0.005484315,0.00005414412,0.003270084,0.00004739056],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971117,0.001430155,0.0001935264,0.0000970677,0.00002335181,0.0005487802,0.0001750089,0.00002201084,0.0003985195],"genre_scores_gemma":[0.9958789,0.001147285,0.0007576878,0.0003508895,0.00007761091,0.0005934336,0.0005926862,0.00001688802,0.0005844965],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00217446,"threshold_uncertainty_score":0.007408619,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08147835014551864,"score_gpt":0.4445169253689405,"score_spread":0.3630385752234219,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}